Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients.
about
Serrated polyposis: an enigmatic model of colorectal cancer predispositionSerrated lesions of the colorectum: review and recommendations from an expert panelEndoscopic and histologic characteristics of serrated lesionsSerrated polyps of right colon: guilty or innocent?The clinical impact of serrated colorectal polypsDNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability.Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical managementFamilial colorectal cancer, beyond Lynch syndromeHistology subtypes and polyp size are associated with synchronous colorectal carcinoma of colorectal serrated polyps: a study of 499 serrated polyps.Cap assisted colonoscopy for the detection of serrated polyps: a post-hoc analysis.Sessile serrated polyps: detection, eradication, and prevention of the evil twinFrequent co-occurrence of high-grade dysplasia in large flat colonic polyps (>20 mm) and synchronous polyps.TFF2-CXCR4 Axis Is Associated with BRAF V600E Colon Cancer.Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.The effect of polyp location and patient gender on the presence of dysplasia in colonic polyps.Sessile serrated adenoma shares similar genetic and epigenetic features with microsatellite unstable colon cancer in a location-dependent mannerType 1 serrated polyposis represents a predominantly female disease with a high prevalence of dysplastic serrated adenomas, without germline mutation in MUTYH, APC, and PTEN genes.Serrated colon polyps as precursors to colorectal cancer.Frequency of coexistent carcinoma in sessile serrated adenoma/polyps and traditional serrated adenomas removed by endoscopic resection.Risk factors for serrated polyps of the colorectum.Detection Rate, Distribution, Clinical and Pathological Features of Colorectal Serrated Polyps.Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT).Colorectal cancer anatomic distribution patterns remain the same after sessile serrated adenoma/polyp considered cancer precursor: a 9-year comparison study from community-based endoscopy centers.Prevalence and Anatomic Distribution of Serrated and Adenomatous Lesions in Patients with Inflammatory Bowel Disease.Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas.Mucins and associated O-glycans based immunoprofile for stratification of colorectal polyps: clinical implication for improved colon surveillance.Serrated polyps: critical precursors to colorectal cancer.Outcomes of a 5-year follow-up of patients with sessile serrated adenomas.Advanced colorectal polyp detection techniques.The natural history of colorectal adenomas and early cancer.The serrated pathway to colorectal carcinoma: current concepts and challenges.Serrated polyps: clinical implications and future directions.Incidence and review of sessile serrated polyp reporting in a district general hospital in the UK.Pathology of serrated colorectal lesions.Serrated neoplasia of the colon: what do we really know?Colorectal serrated pathway cancers and precursors.How does the serrated polyp pathway alter CRC screening and surveillance?Colorectal cancer screening and prevention in women.Systematic Review with Meta-Analysis: Alcohol Consumption and Risk of Colorectal Serrated Polyp.Serrated polyps and the risk of synchronous colorectal advanced neoplasia: a systematic review and meta-analysis.
P2860
Q24623224-4165FED9-7483-4451-BC2D-251BABA1BD5FQ26827208-9DEAE15F-19F1-4C64-9D72-24C255B43484Q27021798-7A9FB786-FD7D-4E3F-B670-50048C1A21EAQ27025004-7088C6E6-5D34-4451-B424-10E304FB9007Q30235429-95319008-1BEB-4CDA-A702-2D29C081FB34Q33904170-AF36D5B6-7858-42C0-8CCD-B7021D22D370Q34034620-D54AEAD2-68D9-4118-8048-1ED13F4A75A8Q34655489-DEBEA019-578A-421C-AA94-B2BBDF1B6447Q34991333-9DF5CE33-6230-4F3D-B201-CEBCFC6877F1Q35102786-3E8BDB2E-3F1F-4FC7-BF1E-95629A1CB58EQ35593741-52B55DE8-CBB1-473A-B108-779D0CF691B1Q35687519-663A1032-E0A9-46FC-B86F-F85623172E3AQ35815682-4D0E8C37-E5AF-4E59-890A-7977B0366D5CQ35831465-2334035C-C12D-43CA-B0C2-B1088DD072C2Q36143257-740DB121-115E-4D61-87CE-E3DE5D2B7582Q36230771-2F9E2F47-EA87-44AD-BC12-537E4FAED9F4Q36719807-CD48AC4A-CDE5-4462-9BAC-D9280D14799CQ36771915-BFC0D615-8647-4F7C-8BFD-21EBB66B0F19Q36798741-556480B6-6661-4A3D-BA0B-BB91D0C93CB9Q36938837-FCC1B85F-0CFB-483A-B91C-0AB1E00C2FF8Q37353594-92DBFDB7-5041-464B-BED7-75F741C6E623Q37495954-D61C8B13-D51F-4335-A14D-EE61CBB88E15Q37525310-CB2A1698-5B38-4610-9E0B-C34655EB98D9Q37611302-D0FD9C25-ADAC-4E61-83AC-EDAC79DC8B26Q37690407-E0E96769-4ABF-45E8-8A38-92DF4D2A439CQ37701721-44A34BFD-BE4F-4E50-B8AD-D0227BAFE624Q37930647-0BED1B79-7FE1-43F2-ABFF-8846C7B14E3BQ37974298-E4DCD918-CE23-4424-8254-4A1DFBA90BDCQ38028365-F7DC4AC4-54E8-44B3-A893-3C291D11C49EQ38040345-CBD31A69-8167-4B7B-B13E-522A7D73A70BQ38075894-B88B9C60-CAF0-40FB-9709-F29D6D5689BDQ38128242-6197AED9-ACD2-4495-BE4C-1CBD4D06F46CQ38131999-9F6D920D-5382-4AB7-B41D-EA90B571AC0CQ38190348-ED3351B3-FD60-4463-85C1-517BE3E2B49CQ38193350-1CA93153-13D6-407B-A987-92EBDD8577C8Q38255029-D76C842B-27AB-477C-B4D4-3C6F6B0A2075Q38306483-48B58256-0CE5-4FDE-87CB-8BBB6D14AF99Q38321887-2D6468D2-82D5-478C-8C73-1E315416A99DQ38331116-594E3E8D-2D98-4089-A95A-7E54D3CCBBB3Q38371825-43B95004-EA6C-476C-B3EE-834CD8357351
P2860
Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients.
@en
Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients.
@nl
type
label
Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients.
@en
Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients.
@nl
prefLabel
Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients.
@en
Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients.
@nl
P2093
P356
P1476
Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients.
@en
P2093
Christopher M Schuler
Richard H Lash
Robert M Genta
P304
P356
10.1136/JCP.2010.075507
P407
P577
2010-06-14T00:00:00Z